Base Technical Content in text and simple images.
The concept of Patient Turnaround Time (P-TAT) is to find out how much time was taken from the identification of the patient for a test to getting the result of that test and initiation of patient's treatment based on the test result.
The National TB Elimination Programme (NTEP) have set benchmarks to monitor the P-TAT as provided in the table below.
Under the National TB Elimination Programme (NTEP), the treatment outcome definitions of Drug-susceptible TB (DS-TB) and Drug-resistant TB (DR-TB) have been aligned in recent times. However, the treatment outcome is declared at different time points for certain outcomes (e.g., cured/ treatment completed) since the duration of DR-TB treatment is longer when compared to DS-TB treatment.
|
TREATMENT OUTCOMES |
DEFINITION |
|---|
The World Health Organization (WHO) defines palliative care as an approach that improves the quality of life of patients and their families facing the problems associated with life-threatening illnesses, through prevention and relief of suffering by means of early identification, impeccable assessment, and treatment of pain and other physical, psychosocial and spiritual problems.
The goal of such treatment is to improve the quality of life for both the patient and their family.
Shift from Shorter to Longer Drug-resistant TB (DR-TB) Regimen
Reasons for regimen shift: Resistance, tolerability, availability and emergence of exclusion criteria.
The inventory of Cartridge Based Nucleic Acid Amplification Test (CBNAAT) cartridges and Truenat chips supplied by the centre or procured by the states/ districts should be managed through Nikshay Aushadhi (see the figure below).
Figure: Inventory Management of NAAT Cartridges/ Chips in Nikshay Aushadhi Portal; Source: Guidelines for PMDT, India, 2021, p142.
The reconstitution of Bedaquiline (Bdq) bottle should be done at the State Drug Store (SDS).
In case of lost to follow-up/ death/ transferred-out/ treatment stopped patients, Bdq bottle shall be brought back from the treatment centre to the Health Facility (HF) to the TB Unit (TU) to the District TB Centre (DTC) within the shortest possible time.
Packaging of loose drugs into monthly patient-wise boxes should be done under the guidance of those in charge of drug logistics at the state and district levels.
Patient-wise drug box preparation should be done for the following Drug-resistant TB (DR-TB) regimens:
Adverse Drug Events are classified on the basis of severity:
1. Serious Adverse Event (SAE) is any untoward medical occurrence that at any dose:
The National TB Elimination Programme (NTEP) utilizes different coloured bags for the segregation of waste generated in TB laboratory settings as shown in the table below.
|
Yellow bag: |
Fluorescence microscopy (FM) is used for TB detection and requires specific tools and reagents which are quality assured.
Following are the tools used for Fluorescence Microscopy (FM) staining:
Reagents used for FM staining are: 0.5% Potassium Permanganate, 1% Acid Alcohol and 0.1% Auramine O
Resources